Question

In: Biology

how do we do the test for factor 5 or V assay for liver disease ?

how do we do the test for factor 5 or V assay for liver disease ?

Solutions

Expert Solution

Answer :- Factor V ( Cofactor of Thromobokinase) is an anticoagulant produced in liver and converts Prothrombin (II - Inactive) to Thrombin (IIa - Active). Its molecular weight is 330 kilodaltons and plasma half life of 12 - 36 hours. Deficiency of factor V (Labile factor or Proaccelerin) can lead slowing of blood clotting process. The acquired deficiences of facor V are common than its congenital deficiences in newborn. The concentration of factor V in blood can be calculated by Factor V Assay, which is summarised as follows:-

1. Whole blood is collected in light blue top tube buffered with anticoagulant sodium citrate.

2. Mix blood with anticoagulant by gentle inversion.

3. Centrifugation of blood for 5 minutes in stat spin centrifuge.

4. Collect plasma from centrifuge tube and pour it into 4 ml BCS sample cup

5. Spin plasma for 5 minutes in same centrifuge.

6. Collect plasma after centrfuge and tranfer it into newsample cup for analysis.

REFERENCE RANGE - 54 - 90% ( 0 - 1 DAY AGE), 70 - 120% ( 2- 5 DAYS AGE), 80 - 116% ( 6-30 DAYS), 69-111% (31-90 DAYS AGE), 73-109%(91-180 DAYS)


Related Solutions

how do we perform fato V assay?
how do we perform fato V assay?
How do we improve post-transplant Liver survival? What do we look for on ultrasound? What are...
How do we improve post-transplant Liver survival? What do we look for on ultrasound? What are the complication? Which one is the most serious complication?
how do we do D-dimer test ?
how do we do D-dimer test ?
How are plant disease classified? And why do we need to classify plant disease?
How are plant disease classified? And why do we need to classify plant disease?
In cell motility assays: a. Do we need to perform a cytotoxicity assay parallel with the...
In cell motility assays: a. Do we need to perform a cytotoxicity assay parallel with the motility assay? Why or why not? b. If you know the IC50 value of the compound to be tested on the motility assay, would you still need to perform the cytotoxicity assay? Why or why not? c. Why do we use a DMSO control in cell-based drug assays? For example, do you need to include a DMSO control in every motility assay? Why or...
Describe the different host related properties of the agent of the disease and how do we...
Describe the different host related properties of the agent of the disease and how do we measure each one of them in terms of rates.
We are only given the accuracy of the blood test and prevalence of the disease in...
We are only given the accuracy of the blood test and prevalence of the disease in our population. We are told that the blood test is 98 percent reliable, this means that the test will yield an accurate positive result in 98% of the cases where the disease is actually present. Gestational diabetes affects 9 percent of the population in our patient’s age group, and that our test has a false positive rate of 12 percent. Use your knowledge of...
write down comparative analysis between BD HPV onclarity assay v/s Qiagen careHPV test for cervical cancer....
write down comparative analysis between BD HPV onclarity assay v/s Qiagen careHPV test for cervical cancer. in which includes Explanation and methodology of both test? if you need any additional information let me know.
a. How do you solve for the clinical sensitivity of an assay? b. If 95 of...
a. How do you solve for the clinical sensitivity of an assay? b. If 95 of 100 patients with a gene mutation are in a disease state, what is the clinical sensitivity for this assay?
When do we use “Tukey’s test for Additivity”? Describe how it works.
When do we use “Tukey’s test for Additivity”? Describe how it works.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT